KEGG   DRUG: D09737Help
Entry
D09737                      Drug                                   

Name
Epoetin kappa (genetical recombination) (Epoetin alfa biosimilar 1) (JAN);
Epoetin kappa (INN);
Epoetin alfa BS (TN)
Formula
C809H1301N229O240S5
Exact mass
18224.5242
Mol weight
18235.7015
Sequence
APPRLICDSR VLERYLLEAK EAENITTGCA EHCSLNENIT VPDTKVNFYA WKRMEVGQQA
VEVWQGLALL SEAVLRGQAL LVNSSQPWEP LQLHVDKAVS GLRSLTTLLR ALGAQKEAIS
PPDAASAAPL RTITADTFRK LFRVYSNFLR GKLKLYTGEA CRTGD
(Disulfide bridge: 7-161; 29-33)
  Type
Peptide
Remark
Therapeutic category: 
ATC code: 
Drug group: 
Comment
See Epoetin alfa [DR:D03231]
Target
erythropoietin receptor agonist [HSA:2057] [KO:K05079]
  Pathway
hsa04060  Cytokine-cytokine receptor interaction
hsa04630  Jak-STAT signaling pathway  
 
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 B BLOOD AND BLOOD FORMING ORGANS
  B03 ANTIANEMIC PREPARATIONS
   B03X OTHER ANTIANEMIC PREPARATIONS
    B03XA Other antianemic preparations
     B03XA01 Erythropoietin
      D09737  Epoetin kappa (genetical recombination) (Epoetin alfa biosimilar 1) (JAN); Epoetin kappa (INN)
Therapeutic category of drugs in Japan [BR:br08301]
 3  Agents affecting metabolism
  39  Other agents affecting metabolism
   399  Miscellaneous
    3999  Others
     D09737  Epoetin kappa (genetical recombination) (Epoetin alfa biosimilar 1) (JAN); Epoetin kappa (INN)
Target-based classification of drugs [BR:br08310]
 Cytokine receptors
  Class I cytokine receptors (hematopoietin family receptors)
   erythropoietin receptor
    Erythropoietin
     D09737  Epoetin kappa (genetical recombination) (Epoetin alfa biosimilar 1) (JAN); Epoetin kappa (INN)
Antineoplastics [BR:br08308]
 Biologic response modifiers
  Myeloid- and erythroid-stimulating factors
   Erythropoietin
    D09737  Epoetin kappa (genetical recombination) (Epoetin alfa biosimilar 1) (JAN); Epoetin kappa (INN)
BRITE hierarchy
Other DBs
CAS: 
879555-13-2
PubChem: 

» Japanese version   » Back

DBGET integrated database retrieval system